sq109
Small moleculeexperimental
Clinical trial activity
7 trials · 14 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2006 (NCT01585636)
Timeline
Indications
Mechanism of action
- Mycobacterium tuberculosisINHIBITOR
Mycobacterium tuberculosis inhibitor
Chemistry & pharmacology
Loading structure…
SMILES
CC(C)=CCC/C(C)=C/CNCCNC1C2CC3CC(C2)CC1C3- Mol. weight
- 330.56 g/mol
- Lipinski Ro5
- Pass
- Rule of 3
- No
- Chirality
- Achiral Molecule
- Inorganic
- No
- Polymer
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL561057 ↗
Also known as
- sq109
- sq109
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT01874314 | Phase 1 | May 23, 2013 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01785186 | Phase 2 | Apr 1, 2013 | European and Developing Countries Clinical Trials Partnership (EDCTP), German Federal Ministry of Education and Research, Ludwig Maximilians University, Medical Research Council, Radboud University, Sequella, Inc. |
| NCT01252108 | Phase 2 | Mar 1, 2012 | Houston Institute for Clinical Research, Sequella, Inc. |
| NCT01358162 | Phase 1 | Nov 1, 2010 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01218217 | Phase 2 | Nov 1, 2010 | CMed Technologies Inc., European and Developing Countries Clinical Trials Partnership (EDCTP), German Federal Ministry of Education and Research, IQVIA, Ludwig Maximilians University, Parexel, PathCare, Sequella, Inc., TASK Applied Science, University of Cape Town |
| NCT00866190 | Phase 1 | Apr 1, 2009 | National Institute of Allergy and Infectious Diseases (NIAID) |
| NCT01585636 | Phase 1 | Sep 1, 2006 | IQVIA, Sequella, Inc. |
Showing 7 of 7 trials
Page 1 / 1
Organizations
Research & Development (14)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Sequella, Inc. | For profit | 4 | 2 | 2 | 2006 |
| National Institute of Allergy and Infectious Diseases (NIAID) | Government | 3 | 3 | 1 | 2009 |
| European and Developing Countries Clinical Trials Partnership (EDCTP) | Academic/Hospital | 2 | 0 | 1 | 2010 |
| German Federal Ministry of Education and Research | Government | 2 | 0 | 1 | 2010 |
| IQVIA | For profit | 2 | 0 | 2 | 2006 |
| Ludwig Maximilians University | Academic/Hospital | 2 | 2 | 1 | 2010 |
| CMed Technologies Inc. | For profit | 1 | 0 | 1 | 2010 |
| Houston Institute for Clinical Research | Academic/Hospital | 1 | 0 | 1 | 2012 |
| Medical Research Council | Government | 1 | 0 | 1 | 2013 |
| Parexel | For profit | 1 | 0 | 1 | 2010 |
| PathCare | For profit | 1 | 0 | 1 | 2010 |
| Radboud University | Academic/Hospital | 1 | 0 | 1 | 2013 |
| TASK Applied Science | For profit | 1 | 0 | 1 | 2010 |
| University of Cape Town | Academic/Hospital | 1 | 0 | 1 | 2010 |
14 organizations
Page 1 / 1